Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is the most common form of irreversible blindness in developed countries. Variants in the factor H gene (CFH, also known as HF1), which encodes a major inhibitor of the alternative complement pathway, are associated with the risk for developing AMD. Here we test the hypothesis that variation in genes encoding other regulatory proteins of the same pathway is associated with AMD. We screened factor B (BF) and complement component 2 (C2) genes, located in the major histocompatibility complex class III region, for genetic variation in two independent cohorts comprising approximately 900 individuals with AMD and approximately 400 matched controls. Haplotype analyses identify a statistically significant common risk haplotype (H1) and two protective haplotypes. The L9H variant of BF and the E318D variant of C2 (H10), as well as a variant in intron 10 of C2 and the R32Q variant of BF (H7), confer a significantly reduced risk of AMD (odds ratio = 0.45 and 0.36, respectively). Combined analysis of the C2 and BF haplotypes and CFH variants shows that variation in the two loci can predict the clinical outcome in 74% of the affected individuals and 56% of the controls. These data expand and refine our understanding of the genetic risk for AMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This analysis resulted in the identification of the previously well documented independently associated variants near CFH and C2/CFB8,10,31,32 and of additional independent signals near C3, CETP, LIPC, FRK/COL10A1, IER3/DDR1, RAD51B (Supplementary Table 6).”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Genes in the complement pathway4–11 and a region of chromosome 10 12,13 have now been implicated as the major genetic contributors to disease.”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“These include complement 2 (C2) and/or complement factor B (CFB) (56), complement 3 (C3) (170), and complement factor I (CFI) (44).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [56]
In the citing paper
“studies have demonstrated that at least one of the two variants associated with AMD—R32Q BF—leads to an impairment in the complement activating function of BF (Gold et al., 2006).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Gold et al., 2006
In the citing paper
“the L9H BF/E318D C2 and R32Q BF/intronic variants of C2 have been shown to be protective for AMD (odds ratio (OR) = 0.45 and 0.36, respectively) by Gold et al.”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Gold et al., 2006
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“Overall type I error rates (α) were retrospectively calculated using a previously described metho”
MethodComplement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
Self-citationBird, A. C., Bressler, N. M., Bressler, S. B., Chisholm, I. H., Coscas, G., Davis, M. D., de Jong, P. T. V. M., Klaver, C. C. W., Klein, B. E. K., Klein, R., et al. (1995) · Survey of Ophthalmology · doi:10.1016/s0039-6257(05)80092-x · Cited by 1,926
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
Self-citationDrusen proteome analysis: an approach to the etiology of age-related macular degeneration
Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222551899 · Cited by 1,208
A Fine-Scale Map of Recombination Rates and Hotspots Across the Human Genome
Myers, S., Bottolo, L., Freeman, C., McVean, G., & Donnelly, P. (2005) · Science · doi:10.1126/science.1117196 · Cited by 1,134 · cited 1×
“Fourth, estimated recombination rates from HapMap data indicate regions of high recombination on both sides of the C2/BF locu”
BackgroundA role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
Self-citation
Cited by
Items 101–200 of 1,000
The complotype: dictating risk for inflammation and infection
Harris, C. L., Heurich, M., Cordoba, S. R. D., & Morgan, B. P. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.06.001 · Cited by 163
Liu, B., Wei, L., Meyerle, C., Tuo, J., Sen, H. N., Li, Z., Chakrabarty, S., Agron, E., Chan, C.-C., Klein, M. L., et al. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-111 · Cited by 164
“Genetic studies have demonstrated strong associations between AMD and several gene variants in genes coding for complement proteins, including complement factor H (CFH), factor B/C2, and C3 [4-12].”
BackgroundRetinal ultrastructure of murine models of dry age-related macular degeneration (AMD)
Ramkumar, H. L., Zhang, J., & Chan, C.-C. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.02.002 · Cited by 163
“To compare the apoE2, apoE3, and apoE4 alleles, transgenic (TR) mice models were made expressing one of the three human APOE isoforms (Sullivan et al., 1997).”
BackgroundInfluentialComplement, Age-Related Macular Degeneration and a Vision of the Future
Gehrs, K. M. (2010) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2010.18 · Cited by 157
Self-citationComplement factor H in AMD: Bridging genetic associations and pathobiology
Toomey, C. B., Johnson, L. V., & Bowes Rickman, C. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.09.001 · Cited by 161
“Subsequently, genetic risk associations were found in other complement genes (Fagerness et al., 2008; Gold et al., 2006b; Maller et al., 2007; Yates et al., 2007) and ushered in an era of intense study of the complement system and its components as therapeutic targets.”
BackgroundGotoh, N., Yamada, R., Hiratani, H., Renault, V., Kuroiwa, S., Monet, M., Toyoda, S., Chida, S., Mandai, M., Otani, A., et al. (2006) · Human Genetics · doi:10.1007/s00439-006-0187-0 · Cited by 160
“Moreover, multiple studies on European descendants recently reported that a missense single nucleotide polymorphism (SNP), rs1061170 (Y402H), in CFH as well as those in LD with rs1061170, are associated with development of ARMD (Conley et al. 2005; Edwards et al. 2005; Hageman et al. 2005; Haines et al. 2005; Klein et…”
BackgroundSloper, J. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.097618 · Cited by 157
Yuan, X., Gu, X., Crabb, J. S., Yue, X., Shadrach, K., Hollyfield, J. G., & Crabb, J. W. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900523-mcp200 · Cited by 156
An update on the genetics of age-related macular degeneration
Scholl, H. P. N., Fleckenstein, M., Issa, P. C., Keilhauer, C. N., Holz, F. G., & Weber, B. H. F. (2007) · PubMed · doi:10.5283/epub.35844 · Cited by 156
Radu, R. A., Hu, J., Yuan, Q., Welch, D. L., Makshanoff, J., Lloyd, M., McMullen, S., Travis, G. H., & Bok, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.191866 · Cited by 157
Regulation of age-related macular degeneration-like pathology by complement factor H
Toomey, C. B., Kelly, U., Saban, D. R., & Bowes Rickman, C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424391112 · Cited by 154
Complement Regulatory Genes and Hemolytic Uremic Syndromes
Kavanagh, D., Richards, A., & Atkinson, J. P. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.59.060106.185110 · Cited by 155
Rohrer, B., Long, Q., Coughlin, B., Wilson, R. B., Huang, Y., Qiao, F., Tang, P. H., Kunchithapautham, K., Gilkeson, G. S., & Tomlinson, S. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2222 · Cited by 154
How does the macula protect itself from oxidative stress?
Handa, J. T. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.03.006 · Cited by 154
“Subsequent studies identified genetic variants in other complement components including C2, CFB (Gold et al., 2006; Spencer et al., 2007), C3 (Maller et al.”
BackgroundSmailhodzic, D., Klaver, C. C. W., Klevering, B. J., Boon, C. J. F., Groenewoud, J. M. M., Kirchhof, B., Daha, M. R., den Hollander, A. I., & Hoyng, C. B. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.07.056 · Cited by 166
Wu, Y., Yanase, E., Feng, X., Siegel, M. M., & Sparrow, J. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913112107 · Cited by 149
Bramall, A. N., Wright, A. F., Jacobson, S. G., & McInnes, R. R. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153227 · Cited by 149
Complement analysis in the 21st century
Mollnes, T. E., Jokiranta, T. S., Truedsson, L., Nilsson, B., de Córdoba, S. R., & Kirschfink, M. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.06.150 · Cited by 153
McKay, G. J., Patterson, C. C., Chakravarthy, U., Dasari, S., Klaver, C. C., Vingerling, J. R., Ho, L., de Jong, P. T. V. M., Fletcher, A. E., Young, I. S., et al. (2011) · Human Mutation · doi:10.1002/humu.21577 · Cited by 151
Self-citationHecker, L. A., Edwards, A. O., Ryu, E., Tosakulwong, N., Baratz, K. H., Brown, W. L., Issa, P. C., Scholl, H. P., Pollok-Kopp, B., Schmid-Kubista, K. E., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp472 · Cited by 147
Arakawa, S., Takahashi, A., Ashikawa, K., Hosono, N., Aoi, T., Yasuda, M., Oshima, Y., Yoshida, S., Enaida, H., Tsuchihashi, T., et al. (2011) · Nature Genetics · doi:10.1038/ng.938 · Cited by 149
Bharti, K., Miller, S. S., & Arnheiter, H. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00772.x · Cited by 146
“Among them are, for instance, the tyrosine402to-histidine substitution in complement factor H, and alleles of ApoE and complement factor C2 ⁄ BF (Baird et al., 2006; Edwards et al., 2005; Gold et al., 2006; Haines et al., 2005; Klein et al., 2005).”
BackgroundOxidative Stress and Antioxidants in Age-Related Macular Degeneration
Kushwah, N. S., Bora, K., Maurya, M., Pavlovich, M. C., & Chen, J. (2023) · Antioxidants · doi:10.3390/antiox12071379 · Cited by 160
Sjöberg, A. P., Trouw, L. A., Clark, S. J., Sjölander, J., Heinegård, D., Sim, R. B., Day, A. J., & Blom, A. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610256200 · Cited by 142
Genome-wide association studies: progress and potential for drug discovery and development
Kingsmore, S. F., Lindquist, I. E., Mudge, J., Gessler, D. D. G., & Beavis, W. D. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2519 · Cited by 189
Smith, R. T., Chan, J. K. W., Busuoic, M., Sivagnanavel, V., Bird, A. C., & Chong, V. N. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1318 · Cited by 158
“This could be significant given that inflammatory pathways (the complement pathways) are now known to be the main substrate for the genetics of AMD.”
BackgroundInfluentialSelf-citationAge-related Macular Degeneration: Genetic and Environmental Factors of Disease
Chen, Y., Bedell, M., & Zhang, K. (2010) · Molecular Interventions · doi:10.1124/mi.10.5.4 · Cited by 161
“Francis PJ, Hamon SC, Ott J, Weleber RG, and Klein ML (2009) Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.”
BackgroundInfluentialSerum Lipid Biomarkers and Hepatic Lipase Gene Associations with Age-Related Macular Degeneration
Reynolds, R., Rosner, B., & Seddon, J. M. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.07.009 · Cited by 140
“Triglycerides 1 30 (21) 76 (24) 2 39 (28) 84 (68) 3 37 (26) 76 (24) 4 34 (24) 82 (26)”
Zarbin, M. A., & Rosenfeld, P. J. (2010) · Retina · doi:10.1097/iae.0b013e3181f57e30 · Cited by 140
Vélez-Montoya, R., Oliver, S. C. N., Olson, J. L., Fine, S. L., Quiroz-Mercado, H., & Mandava, N. (2013) · Retina · doi:10.1097/iae.0000000000000036 · Cited by 154
Mechanism of Inflammation in Age-Related Macular Degeneration
Parmeggiani, F., Romano, M. R., Costagliola, C., Semeraro, F., Incorvaia, C., D’Angelo, S., Perri, P., De Palma, P., De Nadai, K., & Sebastiani, A. (2012) · Mediators of Inflammation · doi:10.1155/2012/546786 · Cited by 135
“comprehensive consideration indicates, once again, that complement-related polymorphic alleles are able to increase (CFH, C3, CFI, and CFHR-2-4-5) or reduce (CFB, C2, and CFHR-1-3) AMD risk, representing a central key point on which the evidences of the high heritability of AMD are based [23, 106, 111].”
BackgroundBazan, N. G., Calandria, J. M., & Serhan, C. N. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r001131 · Cited by 140
Age-related macular degeneration: genome-wide association studies to translation
Black, J. R. M., & Clark, S. J. (2016) · Genetics in Medicine · doi:10.1038/gim.2015.70 · Cited by 136
Complement Activation by Bisretinoid Constituents of RPE Lipofuscin
Zhou, J., Kim, S. R., Westlund, B. S., & Sparrow, J. R. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2868 · Cited by 141
“A common haplotype containing genes for C2 and BF of the classical and alternative pathways, respectively, has also been reported to have an association.(14) The associated variants in C2 and BF are in linkage disequilibrium; therefore, the genetic studies cannot discriminate between them, and involvement of the class…”
Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer’s disease
Zhou, J., Fonseca, M. I., Pisalyaput, K., & Tenner, A. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05558.x · Cited by 130
“The importance of the balance between activation of complement and the effective regulation of the cascade in neurodegenerative disorders has been most recently evident in the association of specific single nucleotide polymorphisms in complement components C3, C2, Factor B, and Factor H, the latter a complement regula…”
BackgroundInflammaging in Skin and Other Tissues - The Roles of Complement System and Macrophage
Zhuang, Y., & Lyga, J. (2014) · Inflammation & Allergy-Drug Targets · doi:10.2174/1871528113666140522112003 · Cited by 132
“They include complement factor H (CFH) [29], complement factor B [30], C3 [31] and C2 [32].”
BackgroundAge-related macular degeneration: diagnosis and management
Cook, H. L., Patel, P. J., & Tufail, A. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldn012 · Cited by 131
Kortvely, E., Hauck, S. M., Duetsch, G., Gloeckner, C. J., Kremmer, E., Alge-Priglinger, C. S., Deeg, C. A., & Ueffing, M. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-3850 · Cited by 135
Age-related macular degeneration and the aging eye
Harris, A., & Wirostko (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s2777 · Cited by 163
“Some of the chromosomal regions associated with AMD include 1q31–32, 6q21 and 10q26 (Gold et al 2006; Swaroop et al 2007).”
BackgroundPark, S., Kim, K., Page, G. P., Allison, D. B., Weindruch, R., & Prolla, T. A. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00496.x · Cited by 134
Thakkinstian, A., McKay, G. J., McEvoy, M., Chakravarthy, U., Chakrabarti, S., Silvestri, G., Kaur, I., Li, X., & Attia, J. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr025 · Cited by 133
The role of complement system in ocular diseases including uveitis and macular degeneration
Jha, P., Bora, P. S., & Bora, N. S. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.06.145 · Cited by 137
IRON TOXICITY AS A POTENTIAL FACTOR IN AMD
WONG, R. W., RICHA, D. C., HAHN, P., GREEN, W. R., & DUNAIEF, J. L. (2007) · Retina · doi:10.1097/iae.0b013e318074c290 · Cited by 131
Age-related macular degeneration and the role of the complement system
McHarg, S., Clark, S. J., Day, A. J., & Bishop, P. N. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.02.032 · Cited by 138
An, E., Lu, X., Flippin, J., Devaney, J. M., Halligan, B., Hoffman, E., Csaky, K., & Hathout, Y. (2006) · Journal of Proteome Research · doi:10.1021/pr060121j · Cited by 130
Age-related macular degeneration and the immune response: implications for therapy
Nussenblatt, R. B., & Ferris, F. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.06.025 · Cited by 130
Age‐Related Macular Degeneration
Cheung, L. K., & Eaton, A. (2013) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1264 · Cited by 120
“16–18 Genetic studies have suggested that polymorphisms in some genes may account for 74% of cases of AMD, and the complement system involved in factor H and in factor B and C2 genes is one of the major factors in the development of AMD.(19) Other modifiable risk factors for AMD include hypertension, obesity, high die…”
BackgroundChen, H., Liu, B., Lukas, T. J., & Neufeld, A. H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002339 · Cited by 129
“and BF/C2 (complement factor B/ complement component 2)”
BackgroundGenome-wide analyses identify common variants associated with macular telangiectasia type 2
Scerri, T. S., Quaglieri, A., Cai, C., Zernant, J., Matsunami, N., Baird, L. M., Scheppke, L., Bonelli, R., Yannuzzi, L. A., Friedlander, M., et al. (2017) · Nature Genetics · doi:10.1038/ng.3799 · Cited by 139
Self-citationFrancis, P. J., Hamon, S. C., Ott, J., Weleber, R. G., & Klein, M. L. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.062737 · Cited by 123
The Genetic Basis of Complex Traits
Iyengar, S. K., & Elston, R. C. (2007) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-389-9_6 · Cited by 118
Bora, N. S., Kaliappan, S., Jha, P., Xu, Q., Sohn, J.-H., Dhaulakhandi, D. B., Kaplan, H. J., & Bora, P. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1872 · Cited by 124
A Linkage between Angiogenesis and Inflammation in Neovascular Age-Related Macular Degeneration
Heloterä, H., & Kaarniranta, K. (2022) · Cells · doi:10.3390/cells11213453 · Cited by 136
Elevated membrane attack complex in human choroid with high risk complement factor H genotypes
Mullins, R. F., Dewald, A. D., Streb, L. M., Wang, K., Kuehn, M. H., & Stone, E. M. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.06.015 · Cited by 122
“AMD-associated variations include polymorphisms in C3 (Maller et al., 2007; Yates et al., 2007), the C2/CFB locus (Gold et al., 2006), and, most notably, complement factor H (CFH) (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
Genetic variants in the complement system predisposing to age-related macular degeneration: A review
Schramm, E. C., Clark, S. J., Triebwasser, M. P., Raychaudhuri, S., Seddon, J. M., & Atkinson, J. P. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.06.032 · Cited by 121
“Both haplotypes are considered highly protective against developing AMD, although the current hypothesis is that the protection is mediated by the FB mutations (Gold et al., 2006; Maller et al., 2006).”
BackgroundYu, Y., Reynolds, R., Fagerness, J., Rosner, B., Daly, M. J., & Seddon, J. M. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-7070 · Cited by 119
“1 Sex Female 116 (52) 463 (57) 548 (58) 129 (50) 477 (58) Male 105 (48) 351 (43) 401 (42) 130 (50) 346 (42) Education High school 155 (70) 587 (72) 656 (69) 163 (63) 473 (57) High school 66 (30) 226 (28) 292 (31) 96 (37) 350 (43) Smoking Never 105 (47) 438 (54) 473 (50) 108 (42) 321 (39) Past 101 (46) 342 (42) 442 (46…”
Yu, Y., Reynolds, R., Rosner, B., Daly, M. J., & Seddon, J. M. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-8657 · Cited by 119
Genetic association with response to intravitreal ranibizumab in patients with neovascular AMD
Kloeckener-Gruissem, B., Barthelmes, D., Labs, S., Schindler, C., Kurz-Levin, M., Michels, S., Fleischhauer, J., Berger, W., Sutter, F., & Menghini, M. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6080 · Cited by 120
“Among them are components of the complement system,(11,12) such as complement factor H (CFH) and component factors C3, C2, and B.(16,17) Other physiological responses, such as stress responses, may also play a role in AMD.”
BackgroundCruz-Guilloty, F., Saeed, A. M., Echegaray, J. J., Duffort, S., Ballmick, A., Tan, Y., Betancourt, M., Viteri, E., Ramkhellawan, G. C., Ewald, E., et al. (2013) · International Journal of Inflammation · doi:10.1155/2013/503725 · Cited by 117
“Hindawi Publishing Corporation International Journal of Inflammation Volume 2013, Article ID 503725, 12 pages http://dx.doi.org/10.1155/2013/503725”
BackgroundInfluentialWu, Z., Lauer, T. W., Sick, A., Hackett, S. F., & Campochiaro, P. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702321200 · Cited by 118
Bazan, N. G. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0918 · Cited by 125
Genetic and Functional Dissection of HTRA1 and LOC387715 in Age-Related Macular Degeneration
Yang, Z., Tong, Z., Chen, Y., Zeng, J., Lu, F., Sun, X., Zhao, C., Wang, K., Davey, L., Chen, H., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000836 · Cited by 114
Herbert, A. P., Deakin, J. A., Schmidt, C. Q., Blaum, B. S., Egan, C., Ferreira, V. P., Pangburn, M. K., Lyon, M., Uhrín, D., & Barlow, P. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609636200 · Cited by 114
Ebrahem, Q., Renganathan, K., Sears, J., Vasanji, A., Gu, X., Lu, L., Salomon, R. G., Crabb, J. W., & Anand-Apte, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601552103 · Cited by 117
Immunopathogenesis of membranous nephropathy: an update
Dêbiec, H., & Ronco, P. M. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0423-y · Cited by 123
“Emphasis has recently been put on mutations and polymorphisms in complement regulatory proteins (CRPs) in diseases such as hemolytic uremic syndrome (HUS) and age-related macular degeneration (AMD) [142–144], although their role in immune complex diseases has not been investigated.”
BackgroundMontes, T., Tortajada, A., Morgan, B. P., Rodríguez de Córdoba, S., & Harris, C. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812584106 · Cited by 112
“Remarkably, although most AMD-associated polymorphisms are linked to increased disease risk, several replication studies have demonstrated that the fB32Q variant confers significant protection from development of AMD (26, 27, 29).”
BackgroundSeddon, J. M., Reynolds, R., Shah, H. R., & Rosner, B. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2010.12.020 · Cited by 115
Choroideremia: New Findings from Ocular Pathology and Review of Recent Literature
MacDonald, I. M., Russell, L., & Chan, C. (2009) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2009.02.008 · Cited by 120
“Localization of inflammatory elements such as complement factors, macrophages, and microglia in AMD lesions support the hypothesis that local inflammation, activation of the complement cascade, and possibly the systemic immune system, contribute to the pathogenesis of AMD.10,16,18,28,30,38,47 Genetic variants in immun…”
BackgroundInfluentialRadeke, M. J., Radeke, C. M., Shih, Y.-H., Hu, J., Bok, D., Johnson, L. V., & Coffey, P. J. (2015) · Genome Medicine · doi:10.1186/s13073-015-0183-x · Cited by 109
“In large part, the analysis focused on genes whose association has been corroborated in multiple studies or large cohort genome-wide association studies [58–97].”
ResultKikuchi, M., Nakamura, M., Ishikawa, K., Suzuki, T., Nishihara, H., Yamakoshi, T., Nishio, K., Taki, K., Niwa, T., Hamajima, N., et al. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.12.021 · Cited by 119
Cameron, D. J., Yang, Z., Gibbs, D., Chen, H., Kaminoh, Y., Jorgensen, A., Zeng, J., Luo, L., Brinton, E., Brinton, G., et al. (2007) · Cell Cycle · doi:10.4161/cc.6.9.4157 · Cited by 114
Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells
Skeie, J. M., Fingert, J. H., Russell, S. R., Stone, E. M., & Mullins, R. F. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5322 · Cited by 114
Complement dysregulation and disease: From genes and proteins to diagnostics and drugs
de Córdoba, S. R., Tortajada, A., Harris, C. L., & Morgan, B. P. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.021 · Cited by 123
Lechner, J., Chen, M., Hogg, R. E., Toth, L., Silvestri, G., Chakravarthy, U., & Xu, H. (2016) · Immunity & Ageing · doi:10.1186/s12979-016-0060-5 · Cited by 114
“Many of the genetic variants that have been associated with AMD lie in genes involved in the complement cascade, including complement factor H (CFH) [9], complement component 3 (C3) [10], complement component 2 (C2) and complement factor B (CFB) [11].”
BackgroundComplement in multiple sclerosis: its role in disease and potential as a biomarker
Ingram, G., Hakobyan, S., Robertson, N. P., & Morgan, B. P. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03830.x · Cited by 110
Inflammation and Age-Related Macular Degeneration (AMD)
Telander, D. G. (2011) · Seminars in Ophthalmology · doi:10.3109/08820538.2011.570849 · Cited by 110
Neovascular Age-Related Macular Degeneration Risk Based on CFH, LOC387715/HTRA1, and Smoking
Hughes, A. E., Orr, N., Patterson, C., Esfandiary, H., Hogg, R., McConnell, V., Silvestri, G., & Chakravarthy, U. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040355 · Cited by 108
“Interaction between CFH and the genes encoding complement C2 or complement factor B [38], and CFH and an excision repair gene named ERCC6 [39] await confirmation.”
BackgroundKenney, M. C., Chwa, M., Atilano, S. R., Falatoonzadeh, P., Ramírez, C., Malik, D., Tarek, M., Cáceres‐del‐Carpio, J., Nesburn, A. B., Boyer, D. S., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu065 · Cited by 116
Association of complement factor H polymorphisms with exudative age-related macular degeneration.
Chen, L. J., Liu, D. T. L., Tam, P. O. S., Chan, W. M., Liu, K., Chong, K. K. L., Lam, D. S. C., & Pang, C. P. (2006) · PubMed · Cited by 124
Genetics of preeclampsia: paradigm shifts
Oudejans, C. B. M., van Dijk, M., Oosterkamp, M., Lachmeijer, A. M. A., & Blankenstein, M. A. (2006) · Human Genetics · doi:10.1007/s00439-006-0259-1 · Cited by 121
“…for the two genes (complement factor B, CBF; complement component 2, C2) associated with age-related macular degeneration and can be expected to be the case for the variant of transcription factor 7-like 2 gene (TCF7L2) associated with type 2 diabetes (Gold et al. 2006; Grant et al. 2006).”
BackgroundThe challenges and promise of complement therapeutics for ocular diseases
Park, D. H., Connor, K. M., & Lambris, J. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01007 · Cited by 108
“36, respectively), although the protection is likely mediated by factor B mutations (42, 43).”
BackgroundWang, J., Ohno‐Matsui, K., Yoshida, T., Shimada, N., Ichinose, S., Sato, T., Mochizuki, M., & Morita, I. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21742 · Cited by 105
“…genes coding for complement factor H and factor B, both of which are key components of the alternative pathway, have been shown to be predictors for the development of AMD (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Gold et al., 2006; Maller et al., 2006).”
BackgroundLee, K. Y., Vithana, E. N., Mathur, R., Yong, V. H. K., Yeo, I. Y. S., Thalamuthu, A., Lee, M., Koh, A. H. C., Lim, M. C. C., How, A. C. S., et al. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0860 · Cited by 109
Review of Genetics in Age Related Macular Degeneration
Montezuma, S. R., Sobrin, L., & Seddon, J. M. (2007) · Seminars in Ophthalmology · doi:10.1080/08820530701745140 · Cited by 106
Lipids, Lipoproteins, and Age-Related Macular Degeneration
Ebrahimi, K. B., & Handa, J. T. (2011) · Journal of Lipids · doi:10.1155/2011/802059 · Cited by 105
Crabb, J. W. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017194 · Cited by 100
“2005), complement factor B (Gold et al. 2006), complement C3 (Yates et al.”
BackgroundInflammation, Complement Factor H, and Age-Related Macular Degeneration
Klein, R., Knudtson, M. D., Klein, B. E. K., Wong, T. Y., Cotch, M. F., Liu, K., Cheng, C. Y., Burke, G. L., Saad, M. F., Jacobs, D. R., et al. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.03.021 · Cited by 106
Functional modules, mutational load and human genetic disease
Zaghloul, N. A., & Katsanis, N. (2010) · Trends in Genetics · doi:10.1016/j.tig.2010.01.006 · Cited by 104
Landowski, M., Kelly, U., Klingeborn, M., Groelle, M., Ding, J.-D., Grigsby, D., & Bowes Rickman, C. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814014116 · Cited by 103
Macular dystrophies mimicking age-related macular degeneration
Saksens, N. T. M., Fleckenstein, M., Schmitz-Valckenberg, S., Holz, F. G., den Hollander, A. I., KEUNEN, J. E. E., Boon, C. J. F., & Hoyng, C. B. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.11.001 · Cited by 111
“Subsequently, AMD risk variants in other genes involved in the complement cascadewere identified, for example in the complement component 2/factor B (Gold et al., 2006), component 3 (C3) (Maller et al., 2007), and complement factor I genes (Maller et al., 2007).”
BackgroundCadherin 5 is Regulated by Corticosteroids and Associated with Central Serous Chorioretinopathy
Schubert, C., Pryds, A., Zeng, S., Xie, Y., Freund, K. B., Spaide, R. F., Merriam, J. C., BARBAZETTO, I. A., Slakter, J. S., Chang, S., et al. (2014) · Human Mutation · doi:10.1002/humu.22551 · Cited by 105
“%) males), who had also been involved in our previous studies of AMD [Gold et al., 2006].”
Self-citationVogt, S. D., Curcio, C. A., Wang, L., Li, C.-M., McGwin, G., Medeiros, N. E., Philp, N. J., Kimble, J. A., & Read, R. W. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.06.002 · Cited by 104
“(Gold et al., 2006) (Maller et al., 2007).”
Ao, J., Wood, J. P. M., Chidlow, G., Gillies, M. C., & Casson, R. J. (2018) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13121 · Cited by 112
The role of the gut microbiome in eye diseases
Zysset‐Burri, D. C., Morandi, S. C., Herzog, E. L., Berger, L., & Zinkernagel, M. S. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101117 · Cited by 112
Ramprasad, V. L., George, R. J., Soumittra, N., Sharmila, F., Vijaya, L., & Kumaramanickavel, G. (2008) · PubMed Central · Cited by 117
Marcheselli, V. L., Mukherjee, P. K., Arita, M., Hong, S., Antony, R., Sheets, K., Winkler, J. W., Petasis, N. A., Serhan, C. N., & Bazan, N. G. (2010) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.10.010 · Cited by 100
Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration
Spencer, K. L., Hauser, M. A., Olson, L. M., Schmidt, S., Scott, W. K., Gallins, P., Agarwal, A., Postel, E. A., Pericak-Vance, M. A., & Haines, J. L. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm369 · Cited by 102
“Furthermore, polymorphisms that reduce the risk of AMD are now being identified, including variants in factor B and complement component 2 on chromosome 6 (10,11).”
BackgroundZipfel, P. F., Lauer, N., & Skerka, C. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5635-4_2 · Cited by 115
“C2, Factor B and C3 Polymorphisms in complement component C2 (E318D) and Factor B (L9H, R32Q) are protective for AMD development (Gold et al. 2006).”
BackgroundInfluentialNatoli, R., Fernando, N., Jiao, H., Racic, T., Madigan, M., Barnett, N. L., Chu-Tan, J. A., Valter, K., Provis, J., & Rutar, M. (2017) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.17-21672 · Cited by 97
Hollyfield, J. G., Perez, V. L., & Salomon, R. G. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8110-z · Cited by 97
Metadata
- Authors
- The AMD Genetics Clinical Study Group, Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., Barile, G. R., Smith, R. T., Hageman, G. S., Dean, M., & Allikmets, R.
- Affiliations
- National Cancer Institute (US)
- Columbia University (US)
- University of Iowa (US)
- Science Applications International Corporation (United States) (US)
- Corresponding author
- Dean, Michael
- Allikmets, Rando
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-03-05
- Volume
- 38
- Issue
- 4
- Pages
- 458-462
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC2921703
- OpenAlex
- W1997288094
- Cited by
- 1,075
- References
- 31
- Citations by year
- 2026: 17 · 2025: 17 · 2024: 18 · 2023: 17 · 2022: 27 · 2021: 40 · 2020: 33 · 2019: 28 · 2018: 27 · 2017: 31 · 2016: 47 · 2015: 65 · 2014: 74 · 2013: 69 · 2012: 90
- FWCI
- 85.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Eye Institute (EY11515, R01EY013435, EY-13435, R01EY015520, R01EY011515)
- National Cancer Institute (N01-CO-124000)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- age-related macular degeneration, factor B, alternative complement pathway, genetic risk variants, haplotypes, complement factor H, MHC class III, genetic susceptibility
- MeSH terms
- Aged, Aged, 80 and over, Aging, Chromatography, High Pressure Liquid, Complement C2, Haplotypes, Humans, Immunohistochemistry, Macular Degeneration, Molecular Sequence Data, Complement Factor B, Cohort Studies, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.